Abacus Planning Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $519K | Buy |
5,013
+61
| +1% | +$5.45K | 0.06% | 138 |
|
|
2026
Q1 | $356K | Sell |
4,952
-638
| -11% | -$49.1K | 0.05% | 176 |
|
|
2025
Q4 | $444K | Buy |
5,590
+504
| +10% | +$39.7K | 0.06% | 150 |
|
|
2025
Q3 | $383K | Sell |
5,086
-274
| -5% | -$18.8K | 0.05% | 159 |
|
|
2025
Q2 | $370K | Sell |
5,360
-653
| -11% | -$42.8K | 0.06% | 162 |
|
|
2025
Q1 | $407K | Buy |
6,013
+731
| +14% | +$43.7K | 0.07% | 136 |
|
|
2024
Q4 | $237K | Sell |
5,282
-264
| -5% | -$14.8K | 0.04% | 186 |
|
|
2024
Q3 | $349K | Buy |
5,546
+79
| +1% | +$4.61K | 0.06% | 154 |
|
|
2024
Q2 | $323K | Sell |
5,467
-4,064
| -43% | -$254K | 0.06% | 142 |
|
|
2024
Q1 | $760K | Sell |
9,531
-190
| -2% | -$14.5K | 0.15% | 84 |
|
|
2023
Q4 | $768K | Sell |
9,721
-1,380
| -12% | -$98.2K | 0.16% | 82 |
|
|
2023
Q3 | $775K | Sell |
11,101
-1,353
| -11% | -$95.9K | 0.19% | 80 |
|
|
2023
Q2 | $861K | Buy |
12,454
+158
| +1% | +$11.2K | 0.21% | 74 |
|
|
2023
Q1 | $914K | Sell |
12,296
-392
| -3% | -$32.9K | 0.24% | 66 |
|
|
2022
Q4 | $1.18M | Buy |
12,688
+313
| +3% | +$30.2K | 0.32% | 50 |
|
|
2022
Q3 | $1.18M | Sell |
12,375
-191
| -2% | -$18.9K | 0.36% | 49 |
|
|
2022
Q2 | $1.16M | Buy |
12,566
+608
| +5% | +$59.3K | 0.34% | 51 |
|
|
2022
Q1 | $1.21M | Sell |
11,958
-28
| -0.2% | -$2.94K | 0.33% | 53 |
|
|
2021
Q4 | $1.24M | Buy |
11,986
+249
| +2% | +$23K | 0.33% | 57 |
|
|
2021
Q3 | $996K | Buy |
11,737
+468
| +4% | +$39.2K | 0.32% | 58 |
|
|
2021
Q2 | $940K | Sell |
11,269
-62
| -0.5% | -$5.08K | 0.29% | 63 |
|
|
2021
Q1 | $852K | Buy |
11,331
+170
| +2% | +$12.4K | 0.27% | 67 |
|
|
2020
Q4 | $762K | Buy |
11,161
+3,003
| +37% | +$195K | 0.24% | 69 |
|
|
2020
Q3 | $476K | Sell |
8,158
-130
| -2% | -$8.09K | 0.17% | 91 |
|
|
2020
Q2 | $538K | Buy |
8,288
+1,314
| +19% | +$82.7K | 0.22% | 79 |
|
|
2020
Q1 | $414K | Sell |
6,974
-2,543
| -27% | -$170K | 0.2% | 85 |
|
|
2019
Q4 | $707K | Buy |
9,517
+3
| +0% | +$211 | 0.32% | 66 |
|
|
2019
Q3 | $600K | Buy |
9,514
+4,598
| +94% | +$272K | 0.3% | 68 |
|
|
2019
Q2 | $268K | Buy |
4,916
+343
| +8% | +$18.5K | 0.16% | 121 |
|
|
2019
Q1 | $247K | Buy |
4,573
+149
| +3% | +$9.2K | 0.15% | 125 |
|
|
2018
Q4 | $290K | Buy |
4,424
+100
| +2% | +$7.46K | 0.22% | 104 |
|
|
2018
Q3 | $340K | Sell |
4,324
-32
| -0.7% | -$2.29K | 0.23% | 97 |
|
|
2018
Q2 | $280K | Sell |
4,356
-274
| -6% | -$18.1K | 0.21% | 108 |
|
|
2018
Q1 | $288K | Buy |
4,630
+305
| +7% | +$21.9K | 0.23% | 94 |
|
|
2017
Q4 | $314K | Buy |
+4,325
| New | +$314K | 0.32% | 69 |
|
Other funds holding CVS
Abacus Planning Group's CVS Position: Q2 2026 in Review
Abacus Planning Group increased its CVS Health (CVS) stake by 1.2% in Q2 2026, buying an estimated $5.45K and bringing the position to 5,013 shares worth $519K. The position accounts for 0.06% of the portfolio, ranked #138.
Abacus Planning Group first reported a position in CVS in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.24M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Abacus Planning Group held 5,013 shares of CVS Health worth $519K as of Q2 2026.
- Abacus Planning Group bought 61 CVS Health shares in Q2 2026, an estimated $5.45K.
- CVS Health made up 0.06% of Abacus Planning Group's portfolio in Q2 2026, its #138 holding.
- Abacus Planning Group first reported a position in CVS Health in Q4 2017 and has held it in 35 quarters since.
- Abacus Planning Group's CVS Health position peaked at $1.24M in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Abacus Planning Group's 13F filing for Q2 2026, filed 20 Jul 2026.